Share
ISSN: 1665-2681
ANNALS OF HEPATOLOGY is an international open access journal published bimonthly and is funded by Medica Sur Clinical Foundation, Mexico City, Mexico. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin-American Association for the Study of the Liver (ALEH) and the Canadian Association for the Study of the Liver (CASL) and publishes original papers, concise reviews, letters to the Editor, invited editorials, opinions and viewpoints in the field of Hepatology.
ANNALS OF HEPATOLOGY'S main topics are alcoholic liver disease, viral hepatitis (HAV, HBV, HCV, HDV, HEV), NAFLD/NASH, genetic liver diseases, autoimmune hepatitis, drug¿induced liver injury and biliary diseases. The journal's aim is to publish articles focused on basic, clinic care and translational research that seeks to prevent rather than treat the complications of endstage liver disease.
Indexed in:
Scopus, Web of Science, Medline
See moreFollow us:
1.895 (2018)
Impact Factor
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.
© Clarivate Analytics, Journal Citation Reports 2017 2018
Impact Factor 2018
1.895
CiteScore 2018
CiteScore measures average citations received per document published. Read more
CiteScore 2018
1.55
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
SJR
0.628
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
SNIP
0.638
Hide
Issue
Pages 119-226 (March - April 2020)
Editorial
Where is the focus on hepatitis C research after the introduction of DAAs: To Understand, knowledge, prevent or cure hepatitis C?
Ana M. Rivas-Estilla, Sonia A. Lozano-Sepulveda
Ann Hepatol. 2020;19:119-20
Open access
Opinions
Antiretroviral Therapies for Human Immunodeficiency Virus and Liver Disease: Challenges and opportunities
Julio C. Abarca, Leonor Huerta, Nora A. Fierro
Ann Hepatol. 2020;19:121-2
Open access
How far is Mexico from Viral Hepatitis Global Health Sector Strategy 2030 targets
Christian A. García-Sepúlveda, Saul Laguna-Meraz, Arturo Panduro
Ann Hepatol. 2020;19:123-5
Open access
Concise reviews
ABCB4 disease: Many faces of one gene deficiency
Eva Sticova, Milan Jirsa
Ann Hepatol. 2020;19:126-33
Open access
Chronic kidney disease in patients with non-alcoholic fatty liver disease: What the Hepatologist should know?
Stefania Kiapidou, Christina Liava, Maria Kalogirou, Evangelos Akriviadis, Emmanouil Sinakos
Ann Hepatol. 2020;19:134-44
Open access
Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerations
María-Jimena Muciño-Bermejo
Ann Hepatol. 2020;19:145-52
Open access
Original articles
Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil
Carolline Araujo-Mariz, Maria de Fátima P. Militão de Albuquerque, Edmundo P. Lopes, Ricardo A.A. Ximenes, Heloísa R. Lacerda, Demócrito B. Miranda-Filho, Brena B. Lustosa-Martins, André Filipe P. Pastor, Bartolomeu Acioli-Santos
Ann Hepatol. 2020;19:153-60
Open access
HEPLA: A multicenter study on demographic and disease characteristics of patients with hepatitis C in Latin America
Luis Viola, Sebastian Marciano, Luis Colombato, Henrique Coelho, Hugo Cheinquer, Gabriela Bugarin, Fernando Tatsch, Roberto J. Carvalho-Filho, Juan P. Roblero, Adriana Varon, Jaime Holguin, Maria R. Torres-Ibarra, Alma M. Pérez-Ríos
Ann Hepatol. 2020;19:161-5
Open access
Comparative study of impulsiveness and risk behaviors among infected individuals with hepatitis C virus and human T-cell lymphotropic virus type 1
Ricardo Henrique-Araújo, Lucas C. Quarantini, Mychelle Morais-de-Jesus, Ana Paula Jesus-Nunes, Adriana Dantas-Duarte, André C. Caribé, Felipe C. Argolo, Roberta F. Marback, Tarciana V. Costa, Irismar Reis de Oliveira
Ann Hepatol. 2020;19:166-71
Open access
EPA plus DHA improves survival related to a decrease of injury after extended liver ischemia in Sprague-Dawley rats
Nicole Céspedes, Andrea Tamayo, Maria Jose Rodriguez, Jessica Zúñiga-Hernández
Ann Hepatol. 2020;19:172-8
Open access
A combination of α-fetoprotein, midkine, thioredoxin and a metabolite for predicting hepatocellular carcinoma
Mohamed M. Omran, Khaled Farid, Mona A. Omar, Tarek M. Emran, Fathy M. El-Taweel, Ashraf A. Tabll
Ann Hepatol. 2020;19:179-85
Open access
Low prevalence of anti-hepatitis E virus IgG antibodies in Tepehuanos in Mexico
Cosme Alvarado-Esquivel, Verónica Dayali Gutierrez-Martinez, Eda Guadalupe Ramírez-Valles, Antonio Sifuentes-Alvarez
Ann Hepatol. 2020;19:186-9
Open access
Role of zinc supplementation in the management of chronic liver diseases: A systematic review and meta-analysis
Daniela C. Diglio, Sabrina A. Fernandes, Jessica Stein, André Azeredo-da-Silva, Angelo A. de Mattos, Cristiane V. Tovo
Ann Hepatol. 2020;19:190-6
Open access
Effects of hepatitis B virus infection, alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase on prediabetes and diabetes mellitus: A cohort study
Ting Gan, Ning Cheng, Jiao Ding, Zhiyuan Cheng, Desheng Zhang, Haiyan Li, Juansheng Li, Na Li, Aimin Yang, Xiaoyu Ren, Dian Shi, Hongquan Pu, Xiping Shen, Xiaowei Ren, Xiaobin Hu, Tongzhang Zheng, Yana Bai
Ann Hepatol. 2020;19:197-203
Open access
The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease
Daniel Iluz-Freundlich, Manna Zhang, Julia Uhanova, Gerald Y. Minuk
Ann Hepatol. 2020;19:204-8
Open access
Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies
Siwanon Nawalerspanya, Pimsiri Sripongpun, Naichaya Chamroonkul, Chanon Kongkamol, Teerha Piratvisuth
Ann Hepatol. 2020;19:209-13
Open access
MicroRNA-124a contributes to glucocorticoid resistance in acute-on-chronic liver failure by negatively regulating glucocorticoid receptor alpha
Xin Wang, Hongrui Xu, Yadong Wang, Chuan Shen, Luyuan Ma, Caiyan Zhao
Ann Hepatol. 2020;19:214-21
Open access
Letters to the editor
Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV
Valentina Cacciato, Edoardo Casagrande, Giorgia Bodini, Manuele Furnari, Elisa Marabotto, Federica Grillo, Edoardo G. Giannini
Ann Hepatol. 2020;19:222-5
Open access
Publish in
Annals of Hepatology
Affiliated societies
